company? Let’s change
that.
Don't see your company?
Create a company profileAs a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by Planova™ virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, Planova™ filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers with products, services and expertise to achieve assurance that is beyond expectation. As part of our dedication to solving therapeutic product safety, efficiency and purity challenges, we also manufacture a comprehensive suite of downstream equipment. With technology platforms for virus filtration, chromatography, inline buffer formulation and oligonucleotide synthesis, our bioprocessing systems, columns and automation solutions advance GMP manufacturing of critical drug substances around the world. Our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.
Eton Bioscience Inc. is a biotech company specializing in DNA sequencing and oligo synthesis services nationwide. Founded in 2003 in San Diego, California, we have been providing scientists of both academia and industry with a variety of services and products to assist them in research. At Eton we strive to provide only the best through our high quality and reliable services, customer care and competitive pricing. We understand that by developing and utilizing the latest innovative techniques, sustainable practices, and efficiency, we are on the way to becoming the number one DNA sequencing company in the nation. Taking pride in what we do, we deliver science, not words.
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients.
Empire Genomics is a leader in the field of molecular diagnostic services for oncology diseases.
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.
US BIOLOGIC’s proprietary oral-delivery system is changing global disease prevention.
Imagion Biosystems is a Biotechnology Company.
Glympse’s mission is to measure protein activity to transform the way patients are diagnosed, monitored and treated. At Glympse, you’ll find an entrepreneurial team that shares a commitment to excellence, an impatience with the status quo, and a desire to drive innovation for patients in need.
BioIntervene is engages in drug discovery and development.
For more than four decades, BioReference has built a legacy based on scientific excellence, innovation and world-class service in laboratory testing solutions. Amidst a tidal wave of change in healthcare in recent years, BioReference has evolved, adding significant services and solutions aimed at addressing the needs of today’s customers. Laboratory testing remains the cornerstone to the services we provide. As we challenge the limits of specialty diagnostics, we are making strategic investments to continue drive innovation and cultivate a unique customer experience, as well as expanding our reach to match the dynamic needs of an ever-changing healthcare system. BioReference offers scientific expertise and laboratory innovation in oncology, urology, and women’s health. Our organization provides credible and tailored solutions for a wide spectrum of customers and patients, including medical practices small and large, hospitals and health systems, correctional institutions, government agencies, educational systems, sport leagues, travel and leisure industries, and retail markets. In addition to an extensive test menu with 99% of tests performed in-house, BioReference’s differentiated offerings include large-scale health screening programs, on-demand mobile phlebotomy, and transformative business solutions that optimize laboratory testing and management. BioReference is part of OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets. Headquartered in Elmwood Park, New Jersey, BioReference operates 10 laboratory facilities around the country, is in-network with the largest health plans in the United States, and serves over 19 million patients annually.
MedPro develops medication delivery products with proprietary passive needlestick prevention technology that protects healthcare workers.
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
IDBiologics is a biotech startup that is focused on developing monoclonal antibodies against infectious disease targets with high unmet medical need. The company is located in Nashville, TN and also has an office in San Mateo, CA.
SimBioSys is a technology company on a mission to deploy Computational Oncology to transform decision making and patient experience in Cancer Care. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options computationally to truly individualize treatment.
Totus Medicines is applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Scripps Research is a leader in the discovery and application of biomedical breakthroughs that improve human health. As the world's largest independent non-profit biomedical research facility, we expand the frontiers of science and education and create hope for millions. Scripps Research is ranked #1 for innovation by the Nature Index.
Bio-Tissue is an ophthalmic biologic therapeutics company that develops innovative regenerative healing and hygiene solutions.